Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct;193(5):2293-2299.
doi: 10.1007/s11845-024-03720-7. Epub 2024 Jun 5.

Relationship of lncRNA FTX and miR-186-5p levels with diabetic peripheral neuropathy in type 2 diabetes and its bioinformatics analysis

Baoqiang Guo #  1 , Xiuli Xu #  2 , Xuexiu Chi  3 , Min Wang  4
Affiliations

Relationship of lncRNA FTX and miR-186-5p levels with diabetic peripheral neuropathy in type 2 diabetes and its bioinformatics analysis

Baoqiang Guo et al. Ir J Med Sci. 2024 Oct.

Abstract

Background: Diabetic peripheral neuropathy (DPN) frequently occurs as a secondary condition in individuals with type 2 diabetes mellitus (T2DM).

Objective: To explore the relationship of lncRNA FTX and miR-186-5p levels with DPN in T2DM.

Methods: The study enrolled 50 patients with T2DM and 45 patients with DPN. Expression levels of FTX and miR-186-5p were measured by RT-qPCR. The levels of MDA, GSH, and SOD in the serum were measured to assess the patients' oxidative stress levels. In addition, the target genes of miR-186-5p were analyzed by bioinformatics.

Results: Serum FTX levels were increased and miR-186-5p levels were decreased in patients with T2DM and DPN. Both of them had high diagnostic value for T2DM and DPN. In addition, FTX and miR-186-5p were risk factors for the onset of DPN in people with T2DM and were significantly correlated with oxidative stress indicators in patients.

Conclusion: FTX and miR-186-5p are closely related to the disease progression of DPN in people with T2DM and may become therapeutic targets for DPN in people with T2DM.

Keywords: Diabetic peripheral neuropathy; FTX; Type 2 diabetes mellitus; miR-186-5p.

PubMed Disclaimer

References

    1. Iqbal Z, Azmi S, Yadav R et al (2018) Diabetic peripheral neuropathy: epidemiology, diagnosis, and pharmacotherapy. Clin Ther 40:828–849 - DOI - PubMed
    1. Selvarajah D, Kar D, Khunti K et al (2019) Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening and early intervention. Lancet Diabetes Endocrinol 7:938–948 - DOI - PubMed
    1. Su M, Yu T, Yu Y et al (2022) hsa-miR-607, lncRNA TUG1 and hsa_circ_0071106 can be combined as biomarkers in type 2 diabetes mellitus. Exp Biol Med (Maywood) 247:1609–1618 - DOI - PubMed
    1. Chureau C, Chantalat S, Romito A et al (2011) Ftx is a non-coding RNA which affects Xist expression and chromatin structure within the X-inactivation center region. Hum Mol Genet 20:705–718 - DOI - PubMed
    1. Sheykhi-Sabzehpoush M, Ghasemian M, Khojasteh Pour F et al (2023) Emerging roles of long non-coding RNA FTX in human disorders. Clin Transl Oncol 25:2812–2831 - DOI - PubMed

LinkOut - more resources